| Old Articles: <Older 761-770 Newer> |
 |
The Motley Fool January 28, 2004 Rick Aristotle Munarriz |
Amazon Grace The leading online retailer wraps up a profitable 2003.  |
The Motley Fool January 28, 2004 Bill Mann |
Daddy, What's a Junk Bond? There are some eerie parallels between the '80s junk bond craze and today's stock market.  |
The Motley Fool January 27, 2004 Jeff Hwang |
Merck in the Balance These are troubled times for Merck. Restructuring charges, Zocor sales woes, and a new distribution program hamper earnings.  |
The Motley Fool January 27, 2004 David Nierengarten |
Pfizer's Next Target? Esperion, swallowed by Pfizer last year, shares many similarities with Atherogenics. Investors in the latter, however, should not count on being acquired any time soon by a big pharmaceutical company.  |
The Motley Fool January 27, 2004 Seth Jayson |
Ailing Adaptec The storage-device maker posts stagnant numbers.  |
The Motley Fool January 27, 2004 Jeff Hwang |
AmEx Rides the Recovery Spending by cardmembers and an improving stock market fuel growth.  |
The Motley Fool January 27, 2004 Alyce Lomax |
R.J. Reynolds's Bummin' Smokes Discount cigarettes smoked out RJR's fourth quarter.  |
The Motley Fool January 27, 2004 Tim Beyers |
Sysco's Unsatisfying Valuation Sysco reports better Q3 earnings, but its valuation lacks meat.  |
The Motley Fool January 27, 2004 W.D. Crotty |
McDonald's Is Worth It McDonald's stock may be pricey, but it may also be worth it.  |
The Motley Fool January 27, 2004 David Forrest |
Valuing the Biggest and the Best Some old-school insight into the new economy stocks.  |
| <Older 761-770 Newer> Return to current articles. |